Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

171

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

March 31, 2009

Conditions
Celiac Disease
Interventions
DRUG

larazotide acetate

gelatin capsules

DRUG

placebo

gelatin capsules

DIETARY_SUPPLEMENT

900 mg gluten

gelatin capsules

Trial Locations (23)

10032

Study Site, New York

15243

Study Site, Pittsburgh

19107

Study Site, Philadelphia

21740

Study Site, Hagerstown

23298

Study Site, Richmond

28801

Study Site, Asheville

40536

Study Site, Lexington

44195

Study Site, Cleveland

48084

Study Site, Troy

55905

Study Site, Rochester

60637

Study Site, Chicago

75093

Study Site, Plano

77030

Study Site, Houston

80907

Study Site, Colorado Springs

85259

Study Site, Scottsdale

98101

Study Site, Seattle

02215

Study Site, Boston

Unknown

Study Site, Edmonton

Study Site, Kelowna

Study Site, Calgary

Study Site, Montreal

Study Site, Toronto

Study Site, Winnipeg

Sponsors
All Listed Sponsors
lead

9 Meters Biopharma, Inc.

INDUSTRY